Correlation Between Adial Pharmaceuticals and Ocugen
Can any of the company-specific risk be diversified away by investing in both Adial Pharmaceuticals and Ocugen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Adial Pharmaceuticals and Ocugen into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Adial Pharmaceuticals and Ocugen Inc, you can compare the effects of market volatilities on Adial Pharmaceuticals and Ocugen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Adial Pharmaceuticals with a short position of Ocugen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Adial Pharmaceuticals and Ocugen.
Diversification Opportunities for Adial Pharmaceuticals and Ocugen
0.15 | Correlation Coefficient |
Average diversification
The 3 months correlation between Adial and Ocugen is 0.15. Overlapping area represents the amount of risk that can be diversified away by holding Adial Pharmaceuticals and Ocugen Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ocugen Inc and Adial Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Adial Pharmaceuticals are associated (or correlated) with Ocugen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ocugen Inc has no effect on the direction of Adial Pharmaceuticals i.e., Adial Pharmaceuticals and Ocugen go up and down completely randomly.
Pair Corralation between Adial Pharmaceuticals and Ocugen
Given the investment horizon of 90 days Adial Pharmaceuticals is expected to under-perform the Ocugen. In addition to that, Adial Pharmaceuticals is 1.08 times more volatile than Ocugen Inc. It trades about -0.3 of its total potential returns per unit of risk. Ocugen Inc is currently generating about -0.29 per unit of volatility. If you would invest 90.00 in Ocugen Inc on November 2, 2024 and sell it today you would lose (17.26) from holding Ocugen Inc or give up 19.18% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Adial Pharmaceuticals vs. Ocugen Inc
Performance |
| Timeline |
| Adial Pharmaceuticals |
| Ocugen Inc |
Adial Pharmaceuticals and Ocugen Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Adial Pharmaceuticals and Ocugen
The main advantage of trading using opposite Adial Pharmaceuticals and Ocugen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Adial Pharmaceuticals position performs unexpectedly, Ocugen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ocugen will offset losses from the drop in Ocugen's long position.| Adial Pharmaceuticals vs. Transcode Therapeutics | Adial Pharmaceuticals vs. Aditxt Inc | Adial Pharmaceuticals vs. Reviva Pharmaceuticals Holdings | Adial Pharmaceuticals vs. Avenue Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Complementary Tools
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| CEOs Directory Screen CEOs from public companies around the world |